More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with ...

You’ve probably heard that dogs can be trained to sniff out cancer. Now, the startup SpotItEarly is harnessing that remarkable ability — along with groundbreaking technology — to launch medicine’s ...

Researchers at Michigan State University created an insect brain-based gas sensing platform to detect lung cancer cell lines. With more development, the technology could be used to detect cancer and ...

Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91%. While colonoscopy remains the gold ...

Every October, it seems like there’s a pink ribbon—the universal symbol for breast cancer—everywhere you go. However, most people may not even recognize an ovarian cancer awareness ribbon unless ...